Zhitong Tech's ANIM-100 Surgical Microscope Receives NMPA Approval, Paving the Way for IPO

Feb 08, 2025 14:30 CST Updated 14:30

AINNOVI

Developer of Microscopic External Vision Surgical Systems

AINNOVI New Product Receives Certification

A New Chapter in Medical Innovation

Just after the Year of the Snake Spring Festival, on February 7, AINNOVI's self-developed ANIM-100 surgical microscope, which has independent intellectual property rights, successfully obtained a Class II medical device registration certificate and received NMPA approval for marketing. This is the second registration certificate obtained by AINNOVI following the "3D Digital Imaging Observation System," marking the maturity of the company’s R&D team in intelligent optical imaging and ultra-high-resolution stereoscopic vision technology. It also represents another significant breakthrough by AINNOVI in the field of medical technology innovation, injecting new vitality into the development of China's medical industry, especially in the import substitution of high-end medical equipment.

ANIM-100 Surgical Microscope is an innovative product developed for refined microsurgical procedures. It integrates advanced technologies such as precision optical design, 4K ultra-high-definition resolution, 3D stereoscopic vision recording, and immersive screen-based surgical operation. With exceptional clarity and an ultra-large depth of field, combined with a 55-inch 4K 3D display, whether it’s the surgeon, assistants, or other operating room staff, everyone can experience an unparalleled stereoscopic surgical view through 3D glasses. AINNOVI, with its strong R&D capabilities, has developed ANIM-100 as the company's sixth medical device and its first high-end surgical microscope system. It offers microsurgery a new operational model—externally visualized screen-based surgery—with high precision, high safety, and ease of use. Having been successfully applied in nearly 3,000 clinical surgeries, ANIM-100 has excelled in complex procedures across spinal surgery, ENT, neurosurgery, and hand-foot surgery. Not only does it effectively enhance surgical accuracy, reduce operation time, and improve surgeon comfort, but it also provides doctors with a powerful tool for teaching and academic presentations while offering patients a better healthcare experience and hope for recovery.

From the initial concept proposal to product development, and finally to obtaining certification, AINNOVI's research and development team has undergone three years of relentless efforts. Throughout this process, the team overcame numerous technical challenges, conducted thousands of tests and clinical validations, adhering to a scientific, rigorous, fact-based, and初心-driven attitude, ultimately passing all verifications with high standards. This certification not only represents high recognition of the R&D team's professional capabilities and innovative spirit but also marks that AINNOVI has reached a new and higher level in the field of medical device research and development.

The successful certification of ANIM-100 will help AINNOVI further expand its presence in the microsurgery market and enhance brand influence. The company will take this as an opportunity to increase investment in research and development and production, continuously launching more high-quality, innovative medical device products to contribute more significantly to global healthcare. Meanwhile, the product's market launch will also bring new solutions to the medical industry, promoting technological advancement and development in the field of microsurgical visualization.

In the future, AINNOVI will continue to uphold the great vision of letting technology meet beauty, focus on the research and development of key technologies for visual perception and intelligent decision-making in surgical scenarios, concentrate on the core product mainline direction of ultra-high-definition stereoscopic vision technology and intelligent human-computer interaction technology, and build a company development strategy of "computational imaging + industry application." It will adhere to innovation-driven technological advancement and patient demand orientation, continuously explore and innovate, and strive to become an industry leader in refined visual imaging technology and a global provider of high-end medical imaging modules, equipment, and digital surgical solutions, creating more value for the cause of human health.